BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18560381)

  • 1. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
    Breig O; Théoleyre O; Douablin A; Baklouti F
    Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
    Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
    Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
    Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
    Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells.
    Gutiérrez P; Delgado MD; Richard C; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):862-8. PubMed ID: 9398659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NACA is a positive regulator of human erythroid-cell differentiation.
    Lopez S; Stuhl L; Fichelson S; Dubart-Kupperschmitt A; St Arnaud R; Galindo JR; Murati A; Berda N; Dubreuil P; Gomez S
    J Cell Sci; 2005 Apr; 118(Pt 8):1595-605. PubMed ID: 15784678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
    DeKoter RP; Geadah M; Khoosal S; Xu LS; Thillainadesan G; Torchia J; Chin SS; Garrett-Sinha LA
    J Immunol; 2010 Dec; 185(12):7374-84. PubMed ID: 21057087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GOOSECOID inhibits erythrocyte differentiation by competing with Rb for PU.1 binding in murine cells.
    Konishi Y; Tominaga M; Watanabe Y; Imamura F; Goldfarb A; Maki R; Blum M; De Robertis EM; Tominaga A
    Oncogene; 1999 Nov; 18(48):6795-805. PubMed ID: 10597288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
    Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
    Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
    Breig O; Théoleyre-Schaal O; Baklouti F
    Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 positively regulates GATA-1 expression in mast cells.
    Takemoto CM; Brandal S; Jegga AG; Lee YN; Shahlaee A; Ying Y; Dekoter R; McDevitt MA
    J Immunol; 2010 Apr; 184(8):4349-61. PubMed ID: 20304827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
    Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
    Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.